Advertisement
Screener

BIOATLA, INC. (BCAB) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

BIOATLA, INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

BIOATLA, INC. (BCAB) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $12.83 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-03-31

  • BIOATLA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $12.83M, a 24.59% decline from fiscal 2024.
  • BIOATLA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $17.01M, a 41.20% decline from fiscal 2023.
  • BIOATLA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $28.94M, a 23.90% increase from fiscal 2022.
  • BIOATLA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $23.36M, a 13.47% increase from fiscal 2021.
Period endEffective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month
2025-12-31$12.83M
10-K · filed 2026-03-31
2024-12-31$17.01M
10-K · filed 2026-03-31
2023-12-31$28.94M
10-K · filed 2025-03-28
2022-12-31$23.36M
10-K · filed 2024-03-26
2021-12-31$20.58M
10-K · filed 2023-03-23
2020-12-31$12.77M
10-K · filed 2022-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXOZYMES INC. (EXOZ)United States$0.058B
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02